Praxis Precision Medicines, Inc. (PRAX) Stock Overview
Explore Praxis Precision Medicines, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Praxis Precision Medicines, Inc. (PRAX)
Key Financials
Key Financials
Market Cap
10.5B
P/E Ratio
-29.34
EPS (TTM)
$-12.93
ROE
-0.34%
PRAX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Praxis Precision Medicines, Inc. (NASDAQ: PRAX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Praxis Precision Medicines, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of PRAX on the NASDAQ shows an RSI of 59.07, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $200.57 for the NASDAQ listing.
Key metrics behind Praxis Precision Medicines, Inc.'s NASDAQ-traded stock include a P/E ratio of -29.34 and a market capitalization of 10.5B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PRAX on the NASDAQ.